These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35763437)

  • 1. Efficacy and safety of a facial serum containing snail secretion filtrate, Calendula officinalis, and Glycyrrhiza glaba root extract in the treatment of maskne: A randomized placebo-controlled study.
    Puaratanaarunkon T; Washrawirul C; Chuenboonngarm N; Noppakun N; Asawanonda P; Kumtornrut C
    J Cosmet Dermatol; 2022 Oct; 21(10):4470-4478. PubMed ID: 35763437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne.
    Ozolins M; Eady EA; Avery A; Cunliffe WJ; O'Neill C; Simpson NB; Williams HC
    Health Technol Assess; 2005 Jan; 9(1):iii-212. PubMed ID: 15588555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne: Two Phase 3 Randomized Clinical Trials.
    Hebert A; Thiboutot D; Stein Gold L; Cartwright M; Gerloni M; Fragasso E; Mazzetti A
    JAMA Dermatol; 2020 Jun; 156(6):621-630. PubMed ID: 32320027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined 400-600nm and 800-1200nm Intense Pulsed Phototherapy of Facial Acne Vulgaris.
    Knight JM
    J Drugs Dermatol; 2019 Nov; 18(11):1116-1122. PubMed ID: 31741354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phase 2b, Randomized, Double-Blind Vehicle Controlled, Dose Escalation Study Evaluating Clascoterone 0.1%, 0.5%, and 1% Topical Cream in Subjects With Facial Acne.
    Mazzetti A; Moro L; Gerloni M; Cartwright M
    J Drugs Dermatol; 2019 Jun; 18(6):570. PubMed ID: 31251550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 15% Azelaic Acid Gel in the Management of Post-Inflammatory Erythema and Post-Inflammatory Hyperpigmentation in Acne Vulgaris.
    Shucheng H; Zhou X; Du D; Li J; Yu C; Jiang X
    Dermatol Ther (Heidelb); 2024 May; 14(5):1293-1314. PubMed ID: 38734843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of a facial serum and a mask containing salicylic acid and lipohydroxy acid in acne management: A randomized controlled trial.
    Li S; He X; Zhang Z; Zhang XS; Niu YG; Steel A; Wang HT
    J Cosmet Dermatol; 2023 Sep; 22(9):2502-2511. PubMed ID: 36999489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
    Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
    Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a Phase 2, Randomized,Vehicle-Controlled Study Evaluating the Efficacy,Tolerability, and Safety of Daily or Twice Daily SB204 for the Treatment of Acne Vulgaris.
    Eichenfield LF; Gold LS; Nahm WK; Cook-Bolden FE; Pariser DM
    J Drugs Dermatol; 2016 Dec; 15(12):1496-15027. PubMed ID: 28095573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
    Marazzi P; Boorman GC; Donald AE; Davies HD
    J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acne RA-1,2, a novel UV-selective face cream for patients with acne: Efficacy and tolerability results of a randomized, placebo-controlled clinical study.
    Cestone E; Michelotti A; Zanoletti V; Zanardi A; Mantegazza R; Dossena M
    J Cosmet Dermatol; 2017 Jun; 16(2):265-270. PubMed ID: 28133878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maskne: A side effect of wearing face mask and face mask-wearing attitudes and behavior during 1
    Bansal H; Mittal R; Kumar V
    J Family Med Prim Care; 2022 Sep; 11(9):5588-5592. PubMed ID: 36505531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate and Severe Acne Vulgaris in Females: Effect of Age on Efficacy and Tolerability.
    Stein Gold L; Pariser DM; Guenin E
    J Drugs Dermatol; 2019 Dec; 18(12):1218-1225. PubMed ID: 31860209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy of metronidazole by needle-free jet injection combined with blue light therapy in Moderate-to-Severe facial acne vulgaris.
    Yi L; Gao L; Lv L; Zhang B; Chen F; Yang F; Yan W; Jiang L; Li N; Lao Y; Lu J; Huang X
    J Cosmet Dermatol; 2023 Feb; 22(2):569-576. PubMed ID: 36208057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of Cheongsangbangpoong-tang on both inflammatory acne lesions and facial heat in patients with acne vulgaris: A randomized controlled trial protocol.
    Kim K; Kim KI; Lee J
    BMC Complement Altern Med; 2016 Jan; 16():21. PubMed ID: 26800893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tazarotene 0.045% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in Adult Males.
    Cook-Bolden FE; Gold MH; Guenin E
    J Drugs Dermatol; 2020 Jan; 19(1):78-85. PubMed ID: 32023013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Modified Qufeng Runmian Powder () on Acne Vulgaris with Syndromes of Dampness and Blood Stasis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Zhang TB; Bai YP; Yang HY; Liu JL; Cao RQ; Wu ZH; Liu YC
    Chin J Integr Med; 2020 Jul; 26(7):490-496. PubMed ID: 32048170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of Cheongsangbangpoong-tang on both inflammatory acne lesion and facial heat in patients with acne vulgaris: A double-blinded randomized controlled trial.
    Kim B; Kim KI; Lee J; Kim K
    Complement Ther Med; 2019 Jun; 44():110-115. PubMed ID: 31126542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive treatment for acne vulgaris by tranexamic acid.
    Charoenwattanayothin A; Saiwichai T; Chaichalotornkul S
    J Cosmet Dermatol; 2022 Oct; 21(10):4515-4522. PubMed ID: 35388589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled trial to determine the efficacy and safety of lactoferrin with vitamin E and zinc as an oral therapy for mild to moderate acne vulgaris.
    Chan H; Chan G; Santos J; Dee K; Co JK
    Int J Dermatol; 2017 Jun; 56(6):686-690. PubMed ID: 28369875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.